Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Trials of Drugs Used to Treat Postherpetic Neuralgia;Análisis Sistemático y Meta-Análisis de los Datos Sobre Eficaica, Seguridad y Tolerabilidad Obtenidos de Ensayos Controlados Aleatorizados con Fármacos Usados Para Tratar la Neuralgia Posherpética

Annals of Pharmacotherapy

Volumn 45, Issue 12, 2011, Pages 1483-1490

  Edelsberg, John S ^a   Lord, Claudia ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

Author keywords

Amitriptyline; Capsaicin; Divalproex sodium; Gabapentin; Meta analysis; Morphine; Neuropathic pain; Nortriptyline; Postherpetic neuralgia; Pregabalin; Systematic review; Tramadol

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; GABAPENTIN; METHADONE; MORPHINE; NORTRIPTYLINE; PLACEBO; PREGABALIN; TRAMADOL; VALPROATE SEMISODIUM;

ANALGESIA; ARTICLE; ATAXIA; CANCER PAIN; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; HUMAN; MAXIMUM TOLERATED DOSE; MEDLINE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHANTOM PAIN; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RISK FACTOR; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIGEMINUS NEURALGIA; XEROSTOMIA;

ANALGESICS; HUMANS; NEURALGIA, POSTHERPETIC; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SENSORY SYSTEM AGENTS;

EID: 83155193304     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P777     Document Type: Article

References (32)

1. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51.
2. Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 2005;113:215-54. DOI 10.1016/j.pain.2004.10.007
3. Gallagher RM. Management of neuropathic pain: translating mechanistic advances and evidence-based research into clinical practice. Clin J Pain 2006;22(suppl 1):S2-8.
4. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043-52.
5. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-55.
6. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000;20:449-58. DOI 10.1016/S0885-3924(00)00218-9
7. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305. DOI 10.1016/ j.pain.2005.08.013
8. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice ASC. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine 2005;2:e164. DOI 10.1371/journal.pmed.0020164
9. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
10. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005(3):CD005454. DOI 10.1002/14651858.CD005454
11. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review of meta-analysis. Anesth Analg 2005;101:1738-49. DOI 10.1213/01.ANE.0000186348.86792.38
12. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005(3):CD005452. DOI 10.1002/14651858.CD005452
13. Edelsberg J, Oster G. Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? Eur J Pain 2009;13:11-6. DOI 10.1016/e.ejpain.2008.03.012
14. Neuropathic pain. The pharmacological management pain in adult nonspecialist settings. [CG96]. London: National Institute for Health and Clinical Excellence, 2010
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. DOI 10.1016/0197-2456(95)00134-4
16. Deng C. On biostatistics and clinical trials blog. Chunqin Deng, March 2009. http://onbiostatistics.blogspot.com/2009_03_01_archive.html (accessed 2011 Feb 16).
17. Bax L, Yu L-M, Ikeda N, et al. Development and validation of MIX: comprehensive free software for meta-analysis of casual research data. BMC Med Res Methodol 2006;6:50.
18. Rice AS, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 2001;94:215-24. DOI 10.1016/S0304-3959(01)00407-9
19. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998;280:1837-42.
20. Van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006;22:375-84.
21. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-83. DOI 10.1212/01.WNL.0000055433.55136.55
22. Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35. DOI 10.1016/j.pain.2004.01.001
23. Graff-Radford SB, Shaw LR, Nailboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000;16:188-92.
24. Raja, SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia. Neurology 2002;59:1015-21.
25. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21(2 pt 1):265-70.
26. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-26.
27. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-31. DOI 10.1016/S0304-3959(03)00020-4
28. Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM 2005;98:29-34. DOI 10.1093/qjmed/hci005
29. Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide from the clinician. CMAJ 2006;175:265-75. DOI 10.1503/cmaj.060146
30. Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009;25:1677-87.
31. Gatti A, Sabato AF, Occhioni R, Colini Baldeschi G, Reale C. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of multicenter Italian study.
32. Attal N, Cruccu G, Haanpaa G, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69. DOI 10.1111/j.1468-1331.2006.01511.x